[ { "@id": "http://purl.org/np/RAuAeKyOAoSnvLp6P9KCCOv-MDIGCvPOtATe5ibl7lprg#provenance", "@graph": [ { "@id": "http://purl.org/np/RAuAeKyOAoSnvLp6P9KCCOv-MDIGCvPOtATe5ibl7lprg#assertion", "http://www.w3.org/ns/prov#wasAttributedTo": [ { "@id": "https://orcid.org/0000-0002-7641-6446" } ] } ] }, { "@id": "http://purl.org/np/RAuAeKyOAoSnvLp6P9KCCOv-MDIGCvPOtATe5ibl7lprg#Head", "@graph": [ { "@id": "http://purl.org/np/RAuAeKyOAoSnvLp6P9KCCOv-MDIGCvPOtATe5ibl7lprg", "http://www.nanopub.org/nschema#hasAssertion": [ { "@id": "http://purl.org/np/RAuAeKyOAoSnvLp6P9KCCOv-MDIGCvPOtATe5ibl7lprg#assertion" } ], "http://www.nanopub.org/nschema#hasProvenance": [ { "@id": "http://purl.org/np/RAuAeKyOAoSnvLp6P9KCCOv-MDIGCvPOtATe5ibl7lprg#provenance" } ], "http://www.nanopub.org/nschema#hasPublicationInfo": [ { "@id": "http://purl.org/np/RAuAeKyOAoSnvLp6P9KCCOv-MDIGCvPOtATe5ibl7lprg#pubInfo" } ], "@type": [ "http://www.nanopub.org/nschema#Nanopublication" ] } ] }, { "@id": "http://purl.org/np/RAuAeKyOAoSnvLp6P9KCCOv-MDIGCvPOtATe5ibl7lprg#pubInfo", "@graph": [ { "@id": "http://purl.org/np/RAuAeKyOAoSnvLp6P9KCCOv-MDIGCvPOtATe5ibl7lprg#sig", "http://purl.org/nanopub/x/hasAlgorithm": [ { "@value": "RSA" } ], "http://purl.org/nanopub/x/hasPublicKey": [ { "@value": "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCR9fz0fKCdWOWC+pxhkQhEM/ppbdIYe5TLSdj+lJzSlv9mYBaPgrzVezSwwbmhlHBPDZa4/vHycU315BdmUGq+pXllp9+rWFfrb+kBJwhZjpG6BeyyXBsRFz4jmQVxl/ZYHilQTh/XalYzKkEAyTiEMPee4Kz61PaWOKH24CsnOQIDAQAB" } ], "http://purl.org/nanopub/x/hasSignature": [ { "@value": "QvTNDZu0ybkHA2OfJmw6iv4LUleiTt2ZUqZDOLRUzaSSjkfRwAHwi9x0LVdIWC2EdnoI+OL5Np4VTzCkfAeLtVxvMcgwvigU0iSOpvEjIXOOLhclx67wuRqXR89MAbjHkB3PaXQce+S1iBrIogNidN9s9O5tNlKid6Pw/5kpPZ0=" } ], "http://purl.org/nanopub/x/hasSignatureTarget": [ { "@id": "http://purl.org/np/RAuAeKyOAoSnvLp6P9KCCOv-MDIGCvPOtATe5ibl7lprg" } ] }, { "@id": "http://purl.org/np/RAuAeKyOAoSnvLp6P9KCCOv-MDIGCvPOtATe5ibl7lprg", "http://www.w3.org/ns/prov#generatedAtTime": [ { "@value": "2022-09-16T11:48:59.111160", "@type": "http://www.w3.org/2001/XMLSchema#dateTime" } ], "http://www.w3.org/ns/prov#wasAttributedTo": [ { "@id": "https://orcid.org/0000-0002-1501-1082" } ], "https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate": [ { "@id": "http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY" } ] }, { "@id": "https://w3id.org/biolink/vocab/", "http://purl.org/pav/version": [ { "@value": "2.3.0" } ] } ] }, { "@id": "http://purl.org/np/RAuAeKyOAoSnvLp6P9KCCOv-MDIGCvPOtATe5ibl7lprg#assertion", "@graph": [ { "@id": "http://identifiers.org/drugbank/DB00285", "@type": [ "https://w3id.org/biolink/vocab/Drug" ], "http://www.w3.org/2000/01/rdf-schema#label": [ { "@value": "Venlafaxine" } ], "https://w3id.org/biolink/vocab/category": [ { "@id": "https://w3id.org/biolink/vocab/Drug" } ] }, { "@id": "http://purl.obolibrary.org/obo/MONDO_0005277", "@type": [ "https://w3id.org/biolink/vocab/Disease" ], "http://www.w3.org/2000/01/rdf-schema#label": [ { "@value": "Migraine (disorder)" } ], "https://w3id.org/biolink/vocab/category": [ { "@id": "https://w3id.org/biolink/vocab/Disease" } ] }, { "@id": "http://purl.org/np/RAuAeKyOAoSnvLp6P9KCCOv-MDIGCvPOtATe5ibl7lprg#association", "http://www.w3.org/1999/02/22-rdf-syntax-ns#object": [ { "@id": "http://purl.obolibrary.org/obo/MONDO_0005277" } ], "http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate": [ { "@id": "https://w3id.org/biolink/vocab/treats" } ], "http://www.w3.org/1999/02/22-rdf-syntax-ns#subject": [ { "@id": "http://identifiers.org/drugbank/DB00285" } ], "@type": [ "https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation" ], "http://www.w3.org/2000/01/rdf-schema#label": [ { "@value": "Although antidepressants are not the first-line prophylactic strategy for patients with migraine, several clinical trials have proven their effectiveness in the treatment of migraine and related headache disorders (Koch and Jurgens, 2009). Especially TCAs: amitriptyline (Couch and Hassanein, 1979; Jackson et al., 2010; Kalita et al., 2013) and nortriptyline (Holroyd et al., 2001; Jackson et al., 2010) have the best evidence for use in migraine prevention. When amitriptyline is not tolerated by patients, treatment is continued with nortriptyline (Burch, 2019)." } ], "https://w3id.org/biolink/vocab/aggregator_knowledge_source": [ { "@id": "https://w3id.org/biolink/infores/knowledge-collaboratory" } ], "https://w3id.org/biolink/vocab/category": [ { "@id": "https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation" } ], "https://w3id.org/biolink/vocab/has_population_context": [ { "@id": "http://purl.org/np/RAuAeKyOAoSnvLp6P9KCCOv-MDIGCvPOtATe5ibl7lprg#context" } ], "https://w3id.org/biolink/vocab/publications": [ { "@id": "http://www.ncbi.nlm.nih.gov/pubmed/31622593" } ], "https://w3id.org/biolink/vocab/relation": [ { "@id": "http://purl.obolibrary.org/obo/NCIT_C94303" } ] }, { "@id": "http://purl.org/np/RAuAeKyOAoSnvLp6P9KCCOv-MDIGCvPOtATe5ibl7lprg#context", "@type": [ "https://w3id.org/biolink/vocab/Cohort" ], "http://www.w3.org/2000/01/rdf-schema#label": [ { "@value": "Adults" } ], "https://w3id.org/biolink/vocab/category": [ { "@id": "https://w3id.org/biolink/vocab/Cohort" } ] } ] } ]